These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 33946488)

  • 61. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila.
    Wu SC; Cao ZS; Chang KM; Juang JL
    Nat Commun; 2017 Jun; 8(1):24. PubMed ID: 28634323
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction.
    Cho J; Park YJ; Gonzales-Portillo B; Saft M; Cozene B; Sadanandan N; Borlongan CV
    CNS Neurosci Ther; 2021 May; 27(5):505-514. PubMed ID: 33464726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.
    Zhu F; Li C; Chu F; Tian X; Zhu J
    Front Aging Neurosci; 2020; 12():544235. PubMed ID: 33132894
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut Microbiota in Alzheimer's Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress.
    Luca M; Di Mauro M; Di Mauro M; Luca A
    Oxid Med Cell Longev; 2019; 2019():4730539. PubMed ID: 31178961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer's Disease: A Narrative Review.
    Simão DO; Vieira VS; Tosatti JAG; Gomes KB
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960314
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia.
    Daulatzai MA
    CNS Neurol Disord Drug Targets; 2015; 14(1):110-31. PubMed ID: 25642988
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adverse stress, hippocampal networks, and Alzheimer's disease.
    Rothman SM; Mattson MP
    Neuromolecular Med; 2010 Mar; 12(1):56-70. PubMed ID: 19943124
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins.
    Khan MS; Ikram M; Park JS; Park TJ; Kim MO
    Cells; 2020 Apr; 9(4):. PubMed ID: 32244729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.
    Ma L; Jiang X; Huang Q; Chen W; Zhang H; Pei H; Cao Y; Wang H; Li H
    Biomed Pharmacother; 2023 Sep; 165():115244. PubMed ID: 37516021
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes.
    Clark A; Mach N
    J Int Soc Sports Nutr; 2016; 13():43. PubMed ID: 27924137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence.
    Mancuso C; Santangelo R
    Pharmacol Res; 2018 Mar; 129():329-336. PubMed ID: 29233677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
    Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
    Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting the microbiota in pharmacology of psychiatric disorders.
    Pascale A; Marchesi N; Govoni S; Barbieri A
    Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders.
    Queiroz SAL; Ton AMM; Pereira TMC; Campagnaro BP; Martinelli L; Picos A; Campos-Toimil M; Vasquez EC
    Front Psychiatry; 2022; 13():872594. PubMed ID: 35722583
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
    Saeedi M; Rashidy-Pour A
    Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.
    Lin C; Zhao S; Zhu Y; Fan Z; Wang J; Zhang B; Chen Y
    Comput Struct Biotechnol J; 2019; 17():1309-1317. PubMed ID: 31921396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.